Al-Razi Medical Co.
Last Updated:
- 45.80 SAR
- 0.00
- 0.00%
شركة الرازي الطبية
الرازي
Symbol :
9572
ISIN :
SA15R0E4LI18
52-Week Range :
41.10
-
64.30
Turnover Ratio :
0.34
Market :
Saudi Exchange
Sector :
Health Care Equipment & Svc
Industry :
Pharmaceuticals and Biotechnology Research & Development
Sub-Industry :
Basic Information
-
Activity :Al-Razi Medical Co. (known as: ALRAZI ) is a public company, listed on Saudi Exchange “Parallel Market” (NOMU) since June 2023. ALRAZI operates within the pharmaceuticals Research and Biotechnology sector...
-
Industry Group :pharmaceuticals Research and Biotechnology
-
Sub-Industry :
-
ISIN :SA15R0E4LI18
-
Contact Person :
-
Established On:10-Aug-2006
-
Stock Listing On :22-Jun-2023
-
No of Employees :123 Employees as of 2022
-
Outstanding Shares :1,520,000
-
Free Float Shares :
-
Par Value :
-
Paid Capital :
-
Market Cap :
-
Authorized Capital :
Indices Membership
| Action | Date | Index | Provider |
|---|---|---|---|
| Join | 2023 | Parallel Market Capped Index (NomuC) | Saudi Exchange Co |
| Al-Razi Medical Co. |
| Al Badaea, King Abdulaziz Road, Umm Talaa, PO Box 999, Qassim 51951, Kingdom of Saudi Arabia |
| T : +966 16 3329999 |
| F : +966 16 3217777 |
| www.razi.sa |
| info@alraziksa.com |
Management
| Title | Name | As Of |
|---|---|---|
| Chairman: | Yousef Al Areeni | 1995 |
| CEO: | Mohamed Dawoud | 2024 |
| Deputy Chairman: | Abdullah Al Daajan | 2021 |
| Board Member: | Abdulaziz Al Aoud | 2021 |
| Abdulrahman Al Shehbany | 2021 | |
| Muhammad Al Mousa | 2021 |
Reports
| Date | Title | File |
|---|---|---|
| 2024 | ALRAZI Quarterly Financials Report Q2 2024 | |
| 2024 | ALRAZI Annual Financials Report 2023 | |
| 2023 | ALRAZI Quarterly Financials Report Q2 2023 | |
| 2023 | ALRAZI Annual Financials Report 2022 |
